英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
dislodged查看　dislodged　在百度字典中的解释百度英翻中〔查看〕
dislodged查看　dislodged　在Google字典中的解释Google英翻中〔查看〕
dislodged查看　dislodged　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Immunostherapy - Harnessing the Immune System to treat Cancer and . . .
    Contact us |||%3A%3F7%40kDA2%3Fmok%5EDA2%3Fm%3A%3E%3EF%3F%40DUD9JjE96C2A6FE%3A4D%5D4%40%3E
  • ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens . . .
    ImmunOs Therapeutics AG leverages its unique immune system modulating HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases
  • The Next Generation Pipeline - Immunostherapy
    ImmunOs’ HLA-based pipeline includes first-in-class immunotherapies for the treatment of cancer and autoimmune disease The Company’s immuno-oncology pipeline is based on its ability to engage both the innate and the adaptive immune systems with single, multitasking molecules that remodel the tumor microenvironment, enhancing anti-tumor
  • Our Company - Immunostherapy
    ImmunOs Therapeutics AG has developed a proprietary human leukocyte antigen (HLA)-based platform to generate a novel class of biologic therapeutics for the treatment of cancer and autoimmune disease
  • Biology - Immunostherapy
    ImmunOs has created a pipeline of therapies that by targeting inhibitory receptors either activate the immune cells to treat cancer or suppress immune cells for inflammatory diseases The diagram below illustrates the ability of ImmunOs to design therapies that either dial down the activity of immune cells to treat inflammatory diseases or dial
  • ImmunOs HLA-based Platform to Target Multiple Checkpoint Receptors for . . .
    ImmunOs Therapeutics at a Glance •Company founded on discovery of specific HLA molecules associated with inflammatory diseases and protection from infectious diseases •Lead molecule IOS-1002 leverages naturally-occurring HLA molecule discovered in psoriasis patients
  • Management Team - Immunostherapy
    ImmunOs Therapeutics´ team has extensive expertise in the field of drug development and global commercialization in immunology, immunotherapy, and oncology The Company’s mission is to develop the next generation of novel immunotherapeutics that will improve the lives of patients with serious diseases
  • Approach - Immunostherapy
    ImmunOs’ approach is based on the identification of specific human leukocyte antigen (HLA) molecules that hyper-activate the immune system of patients with severe autoimmune disorders
  • ImmunOs Therapeutics AG Receives Public Funding from Eurostars and . . .
    – April 12, 2021 – ImmunOs Therapeutics AG, a Swiss bio-technology company developing a new class of biologics for the treatment of cancer and autoimmune diseases, announced today that is has received public funding from the European Union’s Eurostars-2 Programme
  • ImmunOs HLA-based Therapeutics for Cancer Inflammation
    ImmunOs Therapeutics Company Development 2024-2025 • $ 11 M Series C • Phase 1a trial completion • Pipeline development and partnering 2





中文字典-英文字典  2005-2009